A NEW PROSPECT FOR WEIGHT CONTROL ?

Researchers are excitedly investigating retatrutide, a promising treatment from Eli Lilly, as a significant advance in body loss . Different than many earlier approaches, retatrutide is a dual -action agonist targeting both GLP-1 and GIP, hormones that impact appetite and blood sugar balance. Ear